Evidence map›Paper›PMID 34070905›Full record

ArticleInternational journal of molecular sciences2021

The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion.

Lisa Schneider, Junnan Liu, Cheng Zhang, Anca Azoitei, Sabine Meessen, Xi Zheng, Catharina Cremer, Christian Gorzelanny, Sybille Kempe-Gonzales, Cornelia Brunner and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Lisa SchneiderDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Junnan LiuDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Cheng ZhangDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Anca AzoiteiDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Sabine MeessenDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Xi ZhengDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Catharina CremerDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Christian GorzelannyDepartment of Dermatology und Venerology, UKE, 20246 Hamburg, Germany.ORCID 0000-0002-3788-6429
Sybille Kempe-GonzalesDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, 89075 Ulm, Germany.
Cornelia BrunnerDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, 89075 Ulm, Germany.ORCID 0000-0002-6456-5508
Felix WezelDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.ORCID 0000-0003-0675-181X
Christian BolenzDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Cagatay GunesDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.ORCID 0000-0003-4301-2223
Axel JohnDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
University Hospital Ulm · DEUniversität Hamburg · DE

Funding

Wilhelm Sander-Stiftung 2019.038.1
6 · The paper itself

Abstract

backgroundThe interleukin-1-receptor antagonist IL1RA (encoded by the

objectiveBased on these observations, here we investigated the potential roles of IL1RA, IL1A, and IL1B in bladder cancer cell invasion in vitro.

methodsCell culture, real-time impedance sensing, invasion assays (Boyden chamber, pig bladder model), qPCR, Western blot, ELISA, gene overexpression.

resultsWe observed a loss of IL1RA expression in invasive, high-grade bladder cancer cell lines T24, UMUC-3, and HT1197 while IL1RA expression was readily detectable in the immortalized UROtsa cells, the non-invasive bladder cancer cell line RT4, and in benign patient urothelium. Thus, we modified the invasive human bladder cancer cell line T24 to ectopically express IL1RA, and measured changes in cell migration/invasion using the xCELLigence Real-Time-Cell-Analysis (RTCA) system and the Boyden chamber assay. The real-time observation data showed a significant decrease of cell migration and invasion in T24 cells overexpressing IL1RA (T24-IL1RA), compared to cells harboring an empty vector (T24-EV). Concurrently, tumor cytokines, e.g., IL1B, attenuated the vascular endothelial barrier, which resulted in a reduction of the Cell Index (CI), an impedance-based dimensionless unit. This reduction could be reverted by the simultaneous incubation with IL1RA. Moreover, we used an ex vivo porcine organ culture system to evaluate cell invasion capacity and showed that T24-IL1RA cells showed significantly less invasive capacity compared to parental T24 cells or T24-EV.

conclusionsTaken together, our results indicate an inverse correlation between IL1RA expression and tumor cell invasive capacity and migration, suggesting that IL1RA plays a role in bladder carcinogenesis, while the exact mechanisms by which IL1RA influences tumor cells migration/invasion remain to be clarified in future studies. Furthermore, we confirmed that real-time impedance sensing and the porcine ex vivo organ culture methods are powerful tools to discover differences in cancer cell migration and invasion.

Indexed as

AnimalsCarcinogenesisCell Line, TumorCell MovementCell ProliferationEpithelial CellsGene Expression Regulation, NeoplasticHumansInterleukin-1alphaInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinNeoplasm InvasivenessSignal TransductionSwineUrinary BladderUrinary Bladder NeoplasmsIL1A protein, humanIL1B protein, humanIL1RN protein, humanInterleukin-1alphaInterleukin-1betaInterleukin 1 Receptor Antagonist Proteinbladder cancercytokinesIL1RAinterleukin 1 receptorinvasionmigration

Identifiers

PMID34070905
PMCPMC8198563
OpenAlexW3164953866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.